Kallyope Reports Promising Phase 2b Results for Elismetrep, Introducing a Novel Mechanism for Acute Migraine Treatment Kallyope, a late-stage biotechnology company dedicated to developing innovative therapies for neurological and metabolic…
Inocras & Broad Institute Unveil New TCGA Whole-Genome Insights to Advance Cancer Genomics Researchers from Inocras and the Broad Institute of MIT and Harvard are set to unveil significant new…
Zai Lab Showcases ZL-1503’s Rapid Itch Relief and Anti-Inflammatory Effects in Atopic Diseases Zai Lab Limited has unveiled new preclinical findings highlighting the therapeutic promise of ZL-1503, an investigational bispecific…
Cryo-Cell International, Inc. Reports Fiscal First Quarter 2026 Financial Results Cryo-Cell International a pioneer in the cord blood banking industry, has announced its financial results for the first quarter of…
Atropos Health Unveils Scalable Methodology to Transform Real-World Evidence Generation Atropos Health, a leader in converting real-world clinical data into actionable medical insights, has announced the preprint publication of a…
Mark Farrah Associates Unveils Comprehensive County-Level Health Insurance Market Intelligence Mark Farrah Associates (MFA), a recognized leader in healthcare data analytics and market intelligence solutions, continues to strengthen its position…
BoxSPINE Secures FDA Clearance for DUET™ System, Introducing a New Era in Spinal Fixation BoxSPINE, LLC has announced a significant milestone with the U.S. Food and Drug Administration (FDA) granting…
TriSalus Life Sciences to Present New Data at SIR 2026 Annual Scientific Meeting TriSalus Life Sciences, Inc., a clinical-stage oncology company focused on improving outcomes for patients with solid tumors,…
Healthpeak Properties, Inc. Announces Q1 2026 Earnings Release and Investor Call Details Healthpeak Properties, Inc., a prominent real estate investment trust (REIT) specializing in properties that support healthcare discovery and…
Veradigm Strengthens Leadership with Appointment of Christian Greyenbuhl as Chief Financial Officer Veradigm Inc. (OTCMKTS: MDRX), a prominent provider of clinical, financial, and data-driven solutions designed to support independent healthcare…
GenSight Biologics Reports Q1 2026 Cash Position and Early Access Program Revenue Update GenSight Biologics, a biopharmaceutical company dedicated to the development and commercialization of innovative gene therapies targeting retinal…
Stoke Therapeutics Strengthens Board with Appointment of Dr. Clare Kahn Stoke Therapeutics, Inc., a biotechnology company focused on transforming the treatment landscape for genetic diseases, has announced the appointment of…